[Exacerbation of hepatitis B and the expression of M proteinemia during the treatment of malignant lymphoma: a case study].
Akiyama
J
J
Hayashi
S
S
Masaki
N
N
Fukushima
K
K
Matsukawa
M
M
Yamato
S
S
Shoda
R
R
Muraoka
R
R
Matsueda
Shimojo
E
E
Umeda
N
N
Togawa
A
A
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002353:Carrier State; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006509:Hepatitis B / Q000150:complications*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D010265:Paraproteinemias / Q000150:complications*; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage; D014775:Virus Activation
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone